Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
0.696
+0.035 (5.33%)
Mar 12, 2025, 4:00 PM EST - Market closed
Prelude Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '25 Mar 12, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 38 | 70 | 268 | 287 | 577 | 3,033 | |
| Market Cap Growth | -73.80% | -73.80% | -6.83% | -50.22% | -80.97% | - | |
| Enterprise Value | -77 | -65 | 38 | 65 | 259 | 2,798 | |
| Last Close Price | 0.66 | 1.27 | 4.27 | 6.04 | 12.45 | 71.55 | |
| PS Ratio | 7.16 | 10.02 | - | - | - | - | |
| PB Ratio | 0.28 | 0.53 | 1.13 | 1.47 | 2.02 | 14.29 | |
| P/TBV Ratio | 0.53 | 0.53 | 1.13 | 1.47 | 2.02 | 14.29 | |
| Debt / Equity Ratio | 0.14 | 0.14 | 0.07 | 0.01 | 0.01 | - | |
| Asset Turnover | 0.03 | 0.03 | - | - | - | - | |
| Quick Ratio | 5.21 | 5.21 | 10.67 | 9.30 | 15.17 | 19.19 | |
| Current Ratio | 5.30 | 5.30 | 10.79 | 9.42 | 15.37 | 19.41 | |
| Return on Equity (ROE) | -69.01% | -69.01% | -56.33% | -47.97% | -44.85% | -49.67% | |
| Return on Assets (ROA) | -38.54% | -38.54% | -33.19% | -29.38% | -26.89% | -29.92% | |
| Return on Capital (ROIC) | -43.29% | -43.29% | -36.64% | -31.85% | -28.44% | -32.01% | |
| Earnings Yield | -329.30% | -181.24% | -45.50% | -40.16% | -19.35% | -1.88% | |
| FCF Yield | -268.39% | -147.72% | -41.29% | -30.18% | -14.87% | -1.54% | |
| Buyback Yield / Dilution | -25.60% | -25.60% | -27.41% | -2.87% | -269.03% | -647.86% | |
| Total Shareholder Return | -25.60% | -25.60% | -27.41% | -2.87% | -269.03% | -647.86% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.